The Pacific Northwest Dementia and Aging (PANDA) Neuropathology (NP) Group is a successful cooperative effort between the Alzheimer's Disease (AD) Center at Oregon Health &Science University (OHSU) and the AD Research Center (ADRC) at the University of Washington (UW) that was initiated in July 2003. The initial four Specific Aims of the PANDA NP Group are unchanged from our previous applications: (i) provide diagnostic expertise, (ii) facilitate research, (iii) teach and mentor trainees, and (iv) develop innovative approaches. Two new Specific Aims have been added in this application that are focused on Targeted Molecular Testing (TMT): (v) quantify targeted cerebrospinal fluid (CSF) biomarkers in the UW ADRC CSF Bank that derives in large part from the OHSU ADC and UW ADRC Clinical Cores, and (vi) provide targeted genetic testing relevant to AD and related neurodegenerative diseases. All of our activities are focused on enhancing the research value of tissue and body fluid donations from cognitively healthy individuals and patients with neurodegenerative diseases while insuring proper safeguards.
AD is a looming public health disaster for US citizens, both patients and caregivers, and our health care system. There Is no effective treatment for AD. This application is a response to the need to deepen our understanding of AD so effective treatments can be developed.
|Chichester, Lee; Wylie, Ashley T; Craft, Suzanne et al. (2015) Muscle heat shock protein 70 predicts insulin resistance with aging. J Gerontol A Biol Sci Med Sci 70:155-62|
|Dmitrieva, Natalia O; Fyffe, Denise; Mukherjee, Shubhabrata et al. (2015) Demographic characteristics do not decrease the utility of depressive symptoms assessments: examining the practical impact of item bias in four heterogeneous samples of older adults. Int J Geriatr Psychiatry 30:88-96|
|Petrie, Eric C; Cross, Donna J; Yarnykh, Vasily L et al. (2014) Neuroimaging, behavioral, and psychological sequelae of repetitive combined blast/impact mild traumatic brain injury in Iraq and Afghanistan war veterans. J Neurotrauma 31:425-36|
|Stewart, Tessandra; Sui, Yu-Ting; Gonzalez-Cuyar, Luis F et al. (2014) Cheek cell-derived *-synuclein and DJ-1 do not differentiate Parkinson's disease from control. Neurobiol Aging 35:418-20|
|Millard, Steven P; Lutz, Franziska; Li, Ge et al. (2014) Association of cerebrospinal fluid A*42 with A2M gene in cognitively normal subjects. Neurobiol Aging 35:357-64|
|Cheung, Charles Y K; Thompson, Elizabeth A; Wijsman, Ellen M (2014) Detection of Mendelian consistent genotyping errors in pedigrees. Genet Epidemiol 38:291-9|
|Davis, Marie Y; Keene, C Dirk; Jayadev, Suman et al. (2014) The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects. J Huntingtons Dis 3:209-17|
|Beecham, Gary W; Hamilton, Kara; Naj, Adam C et al. (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet 10:e1004606|
|Hales, Chadwick M; Dammer, Eric B; Diner, Ian et al. (2014) Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease. Brain Pathol 24:344-51|
|Escott-Price, Valentina; Bellenguez, Céline; Wang, Li-San et al. (2014) Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. PLoS One 9:e94661|
Showing the most recent 10 out of 410 publications